Torrent Pharma to acquire Unichem’s India business


Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd has said that  Torrent has entered into a definite agreement with Unichem to acquire  its branded business of Nepal and India for about Rs.3,600 crore.

The transaction is expected to close by the end of 2017.

Unichem’s India business comprises of a portfolio of more than 120 brands it sells in India and Nepal.

Torrent will fund the acquisition through a mix of internal accruals
and bank borrowings.

The acquisition will add a brand of Rs. 200 crores.

Yash Ved
Yash Ved is a Senior Correspondent at NewsBarons and comes with a decade of experience across leading online and offline publications. A keen observer of the stock index movement, Yash also likes covering Real Estate and the BFSI sector. A financial management and Journalism student, Yash believes learning as a continuous journey and enjoys following the IT and the Pharmaceutical industry and has penned many articles on the subjects.